chang helm analyz
pre post-ceo transit
given three large-cap ceo transit across coverag
abbott bd evalu histor pre-
post-transit price perform mean median
basi stock modestli under-perform medic devic
transit outperform follow transit
ceo transit across coverag sinc nearli everi compani
coverag univers exclud recent spin ipo
undergon ceo transit past year look compani
stock under-perform medic devic ceo
transit pt averag outperform medic devic
follow transit pt averag
compar stock perform in-lin
preced transit averag outperform
month follow transit pt respect median
perform indic trend lesser magnitud like
appropri metric given neutral outlier summari
perform metric exhibit comprehens list ceo transit
across coverag past year
exhibit pre post-transit perform
metric reflect price perform measur total return
outperform consid perform stock
led post-transit out-performance trend deviat norm
exhibit exhibit stock-specif rel perform pre- post-ceo
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
leader trend saw greatest rel under-perform
transit vs devic
respect greatest out-performance afterward
month nearli to-dat avano baxter
haemonet also demonstr clear improv
rel price perform post-
notabl deviat notabl deviat compani
outperform nearli pt pre-transit
under-perform magnitud
follow transit similarli revers rel cours
deliv double-digit out-performance
chang offic follow rel price perform
beyond case liam kelli challeng first
year follow materi out-performance second year
pt vs medic devic pt vs
consist perform outperform pre- post-
time period jan zimmer biomet under-perform
follow chang offic dec
case zimmerbiomet bryan hanson second year usher pt
out-performance vs medic devic pt vs
bring least major transit least compani
total coverag vs compani coverag set
new ceo helm year chairman
vincent forlenza step role ceo last week follow
nearli year ceo year compani see thought
abbott chairman ceo mile white retir tenur
although remain execut chairman effect march see
thought chairman omar ishrak hand
rein april remain execut chairman follow nearli
year ceo see thought
relationship view perform across past ceo transit
predict perform transit come especi consid
confound driver idiosyncrat perform analysi
 zimmer biomet avano ip spin major regulatori approv product
launch catalyst said post-
transit out-performance trend notabl mean median basi
broadli speak confid relationship management-
direct strategi execut sharehold return relat thought
incent perform see annual execut compens analysi
date transit
exhibit onward outgo interim incom med-tech ceo
interim ceo case analyz perform base date final incom ceo appoint
 saw ceo transit analyz recent transit
exhibit pre- post- ceo transit perform vs medic devic
date
exhibit pre- post- ceo transit perform vs
date
act financi advisor inc baxter
respect definit agreement baxter acquir seprafilm adhes
barrier relat asset sanofi announc decemb
propos transact subject certain regulatori approv customari close
condit baxter agre pay fee financi servic
includ transact fee conting upon consumm propos
transact pleas refer note end report
